Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 27, 2023, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Revenue from... | April 27, 2023

Related Keywords

Highbridge ,Somerset ,United Kingdom ,Pratteln ,Switzerland General ,Switzerland ,France ,Germany ,United States ,China ,German ,French ,Swiss ,America ,Shabir Hasham ,Andrew Smith ,Eva Kalias ,Bradley Meyer ,Dario Eklund ,Santhera Pharmaceuticals Holding Ltd ,European Commission ,Bonds ,Chiesi Group ,European Medicines Agency ,Strategy Committee ,Advisory Committee Meeting ,Life Science Alliance ,Santhera Pharmaceuticals Holding ,Regulatory Agency ,Exchange Regulation ,Raxone To Chiesi Group ,Highbridge Capital Management ,Exchange Regulation Ltd ,Head Investor Relations Communications ,Swiss Exchange ,Committee For Medicinal Products Human Use ,European Union ,Santhera Pharmaceuticals ,Greater China Region ,Prescription Drug User Fee Act ,Advisory Committee ,Medicinal Products ,Human Use ,United Kingdom Medicines ,North America ,Greater China ,Senior Advisor ,Ducera Partners ,Annual General Meeting ,Extraordinary General Meeting ,Regulation Ltd ,Exchangeable Notes ,Annual Report ,Proc Natl Acad Sci United States ,Head Investor Relations ,Santhera Pharmaceuticals Holding Ag Stock Exchange ,News ,Information ,Press Release ,D ,Oc ,Announcement ,Ursuant ,O ,3 ,Dr ,Conference ,Wall ,Hill ,The ,Held ,N ,Pril ,It ,Pest ,Dust ,Details ,Fire ,He ,End ,F ,This ,Evenue Sann Ch0027148649 ,